147 related articles for article (PubMed ID: 12537516)
1. A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine.
Yin OQ; Tomlinson B; Chow AH; Chow MS
Clin Pharmacokinet; 2003; 42(2):179-92. PubMed ID: 12537516
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two compartmental models for describing ranitidine's plasmatic profiles.
Schaiquevich P; Niselman A; Rubio M
Pharmacol Res; 2002 May; 45(5):399-405. PubMed ID: 12123628
[TBL] [Abstract][Full Text] [Related]
3. Applications and simulations of a discontinuous oral absorption pharmacokinetic model.
Witcher JW; Boudinot FD
Pharm Res; 1996 Nov; 13(11):1720-4. PubMed ID: 8956341
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
Koch KM; Davis IM; Gooding AE; Yin Y
Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
Koch KM; Kerr BM; Gooding AE; Davis IM
Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
[TBL] [Abstract][Full Text] [Related]
6. A simple pharmacokinetics subroutine for modeling double peak phenomenon.
Mirfazaelian A; Mahmoudian M
Biopharm Drug Dispos; 2006 Apr; 27(3):119-24. PubMed ID: 16400712
[TBL] [Abstract][Full Text] [Related]
7. Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles.
Suttle AB; Pollack GM; Brouwer KL
Pharm Res; 1992 Mar; 9(3):350-6. PubMed ID: 1614968
[TBL] [Abstract][Full Text] [Related]
8. Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humans.
Reynolds KS; Song MH; Heizer WD; Burns CB; Sica DA; Brouwer KL
Pharm Res; 1998 Aug; 15(8):1281-5. PubMed ID: 9706062
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double-peak absorption profile after oral administration to human volunteers.
Helmy SA
Biopharm Drug Dispos; 2013 Jul; 34(5):288-301. PubMed ID: 23585286
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
Sasaki M; Sudoh T; Fujimura A
Am J Ther; 2005; 12(3):223-5. PubMed ID: 15891265
[TBL] [Abstract][Full Text] [Related]
11. Effect of Da-Cheng-Qi decoction on the pharmacokinetics of ranitidine in rats.
Tang WF; Wan MH; Huang QR; Zhu ZY; Zhao JL; Wu YZ; Huang X
Biomed Chromatogr; 2008 Aug; 22(8):851-6. PubMed ID: 18384065
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic ranitidine treatment in critically ill children--a population pharmacokinetic study.
Hawwa AF; Westwood PM; Collier PS; Millership JS; Yakkundi S; Thurley G; Shields MD; Nunn AJ; Halliday HL; McElnay JC
Br J Clin Pharmacol; 2013 May; 75(5):1265-76. PubMed ID: 23016949
[TBL] [Abstract][Full Text] [Related]
14. Effects of gender and phase of the menstrual cycle on the kinetics of ranitidine in healthy volunteers.
Flores Pérez J; Juárez Olguín H; Flores Pérez C; Pérez Guillé G; Guillé Pérez A; Camacho Vieyra A; Toledo López A; Carrasco Portugal M; Lares Asseff I
Chronobiol Int; 2003 May; 20(3):485-94. PubMed ID: 12868543
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioequivalence study of ranitidine film tablets in healthy male subjects.
Gschwend MH; Guserle R; Erenmemişoglu A; Martin W; Tamur U; Kanzik I; Hincal AA
Arzneimittelforschung; 2007; 57(6):315-9. PubMed ID: 17688076
[TBL] [Abstract][Full Text] [Related]
16. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
[TBL] [Abstract][Full Text] [Related]
17. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
Bendas ER; Ayres JW
Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
[TBL] [Abstract][Full Text] [Related]
18. Effect of age on the pharmacokinetics of ranitidine in healthy Mexican volunteers.
Pérez-Guillé G; Guillé-Pérez A; Toledo-López A; Juárez-Olguín H; Flores Pérez C; Flores-Pŕez J; Carrasco-Portugal M; Lares-Asseff I; Camacho-Vieyra A
Proc West Pharmacol Soc; 2005; 48():84-8. PubMed ID: 16416668
[TBL] [Abstract][Full Text] [Related]
19. Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat.
Suttle AB; Brouwer KL
Drug Metab Dispos; 1994; 22(2):224-32. PubMed ID: 8013278
[TBL] [Abstract][Full Text] [Related]
20. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]